Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purification of Actinium-225 from Thorium via Selective Precipitation.

Molecules (Basel, Switzerland)·2026
Same author

DFT and Mass Spectrometry Study of (-)ESI-Induced Fragmentation of the Highly Toxic Rodenticide Tetramethylenedisulfotetramine.

ACS omega·2026
Same author

Transient Triamidoamine Neptunium(V)-Mono(Imido) Complexes: C-H Activations and Hydrogen Atom Transfer Driven by Effective Nuclear Charge.

Journal of the American Chemical Society·2026
Same author

Charged Defects in UO<sub>2</sub> Bulk and Surface: A First-Principles Study.

ACS applied materials & interfaces·2026
Same author

Quantifying Outer- and Inner-Coordination Sphere Effects Using Uranium Redox Chemistry in Molten Salt Solutions.

Journal of the American Chemical Society·2026
Same author

Phosphorylation-Dependent Charge Transport in Biomolecular Junctions of Major Histocompatibility Complex Phosphopeptides.

The journal of physical chemistry. B·2026

Related Experiment Video

Updated: Nov 29, 2025

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

8.4K

Computer-Assisted Design of Macrocyclic Chelators for Actinium-225 Radiotherapeutics.

Amanda Morgenstern1, Laura M Lilley2, Benjamin W Stein2

  • 1Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States.

Inorganic Chemistry
|November 20, 2020
PubMed
Summary

Actinium-225 offers cancer treatment potential but requires advanced chelators. This study reveals that maximizing electrostatic interactions and minimizing repulsion are key to designing effective actinium chelators for targeted radiotherapies.

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.4K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.9K

Related Experiment Videos

Last Updated: Nov 29, 2025

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

8.4K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.4K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.9K

Area of Science:

  • Radiochemistry
  • Nuclear Medicine
  • Computational Chemistry

Background:

  • Actinium-225 (225Ac) is a promising alpha-emitting radionuclide for targeted cancer therapy due to its decay properties.
  • Developing stable chelators for 225Ac is crucial for effective *in vivo* delivery but remains challenging due to actinium's unique chemical properties.

Purpose of the Study:

  • To theoretically investigate actinium binding with macrocyclic chelators.
  • To understand how macrocycle size, functional groups, and tether length influence actinium chelation.
  • To establish a foundation for designing improved actinium chelators for radiopharmaceuticals.

Main Methods:

  • Computational modeling of actinium (Ac3+) complexation with various macrocyclic chelating agents.
  • Analysis of bonding interactions, considering factors like ring size and functional group characteristics.
  • Comparison of theoretical binding with established chelators like DOTA4-.

Main Results:

  • Actinium chelation is primarily governed by strong ionic bonding interactions.
  • Optimal chelator design involves maximizing electrostatic attraction between the Ac3+ cation and functional groups.
  • Minimizing electronic repulsion between negatively charged functional groups is also critical for stable binding.

Conclusions:

  • A new strategy for actinium chelator design is proposed, focusing on electrostatic interactions and repulsion minimization.
  • This research provides crucial insights for developing next-generation chelators for 225Ac-based targeted radiotherapies.
  • Understanding the fundamental chemistry of actinium bonding is essential for advancing its clinical applications.